Atlas Trials

A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy

Clinical trial NCT02159690 · WITHDRAWN

Trial details

NCT number
NCT02159690
Sponsor
Kenneth Pienta, MD
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate CancerLocalized Prostate Cancer
Start date
2014-09-01
Primary completion
2015-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.